Detalhe da pesquisa
1.
Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa.
J Am Acad Dermatol
; 83(2): 447-454, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786163
2.
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa.
JCI Insight
; 4(11)2019 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31167965